Using split doses for the first 4 to 8 weeks while adapting to the glucagon component, then consolidating to weekly injections, is a pragmatic approach that some researchers report success with
Mechanisms of GLP-1 receptor agonist-induced weight loss
Due to the high expression profile of GLP-1R in pancreatic -cells, GLP-1 analogs (such as exendin-4) have been modified by different methods (to prolong half-life, maintain receptor binding affinity and reduce renal drug accumulation) for theranostic purposes and serve as excellent templates for future cardiovascular drug development[178-184]
Its like building a custom home for somebody, he says, based on their phenotype, risks, etc
Currently, there are only three medications approved in the U.S
Practical Guidance & Take-Aways Given the lack of clear federal guidance and uniform state regulation, compounders are well-advised to seek advice from experienced healthcare counsel, as there are a number of steps that may reduce enforcement risk